Tang Capital Management as of March 31, 2026
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 51 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals (AUPH) | 9.2 | $181M | 12M | 14.82 | |
| Celcuity (CELC) | 6.1 | $120M | 1.1M | 114.14 | |
| Mirum Pharmaceuticals (MIRM) | 5.8 | $114M | 1.2M | 92.38 | |
| Galapagos Nv Spon Adr (GLPG) | 5.8 | $114M | 3.8M | 30.00 | |
| State Str Spdr S&p 500 Etf T Tr Unit (SPY) | 5.5 | $109M | 168k | 650.34 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 5.5 | $109M | 2.3M | 48.15 | |
| Capricor Therapeutics Com New (CAPR) | 5.2 | $103M | 3.4M | 30.40 | |
| Ptc Therapeutics I (PTCT) | 5.2 | $102M | 1.5M | 68.13 | |
| Spyre Therapeutics Com New (SYRE) | 4.8 | $95M | 1.9M | 50.44 | |
| Kalvista Pharmaceuticals (KALV) | 4.7 | $92M | 4.6M | 20.13 | |
| Compass Therapeutics (CMPX) | 4.5 | $89M | 17M | 5.29 | |
| Tarsus Pharmaceuticals (TARS) | 4.2 | $83M | 1.2M | 70.15 | |
| Immunocore Hldgs Ads (IMCR) | 4.1 | $80M | 2.6M | 30.15 | |
| Anaptysbio Inc Common (ANAB) | 3.7 | $74M | 1.3M | 55.46 | |
| Corcept Therapeutics Incorporated (CORT) | 3.1 | $61M | 1.5M | 40.31 | |
| Biosante Pharmaceuticals (ANIP) | 2.8 | $54M | 708k | 76.90 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $43M | 260k | 163.52 | |
| Biontech Se Sponsored Ads (BNTX) | 2.1 | $42M | 470k | 88.88 | |
| Miragen Therapeutics (VRDN) | 1.8 | $35M | 1.8M | 19.56 | |
| Atea Pharmaceuticals (AVIR) | 1.3 | $26M | 4.8M | 5.38 | |
| Precigen (PGEN) | 1.3 | $25M | 6.4M | 3.87 | |
| Dianthus Therapeutics (DNTH) | 1.1 | $22M | 265k | 83.92 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.1 | $22M | 4.0M | 5.53 | |
| Crescent Biopharma (CBIO) | 1.1 | $21M | 1.2M | 18.37 | |
| Stoke Therapeutics (STOK) | 0.8 | $16M | 500k | 32.56 | |
| Viking Therapeutics (VKTX) | 0.8 | $16M | 500k | 32.54 | |
| Ideaya Biosciences (IDYA) | 0.8 | $15M | 450k | 33.32 | |
| Nuvation Bio Com Cl A (NUVB) | 0.7 | $14M | 3.1M | 4.29 | |
| Pliant Therapeutics (PLRX) | 0.4 | $7.7M | 6.1M | 1.26 | |
| Journey Med Corp (DERM) | 0.4 | $7.6M | 1.6M | 4.69 | |
| Janux Therapeutics (JANX) | 0.4 | $7.0M | 500k | 13.90 | |
| Biogen Idec (BIIB) | 0.3 | $6.4M | 35k | 183.33 | |
| Urogen Pharma (URGN) | 0.3 | $6.3M | 350k | 17.98 | |
| Arvinas Ord (ARVN) | 0.3 | $5.7M | 539k | 10.60 | |
| Pmv Pharmaceuticals (PMVP) | 0.3 | $5.3M | 4.2M | 1.24 | |
| Moderna (MRNA) | 0.3 | $5.1M | 100k | 50.80 | |
| Heron Therapeutics (HRTX) | 0.3 | $5.0M | 6.3M | 0.80 | |
| Kezar Life Sciences Com New (KZR) | 0.3 | $4.9M | 664k | 7.42 | |
| Wave Life Sciences SHS (WVE) | 0.2 | $4.4M | 600k | 7.25 | |
| Lenz Therapeutics (LENZ) | 0.2 | $4.1M | 451k | 9.15 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $3.4M | 100k | 33.83 | |
| Erasca (ERAS) | 0.2 | $3.2M | 200k | 16.18 | |
| Coherus Biosciences (CHRS) | 0.2 | $3.2M | 1.9M | 1.69 | |
| Nkarta (NKTX) | 0.2 | $3.1M | 1.5M | 2.11 | |
| Altimmune Com New (ALT) | 0.1 | $2.1M | 666k | 3.08 | |
| Evolus (EOLS) | 0.1 | $2.0M | 483k | 4.11 | |
| Abeona Therapeutics Com New (ABEO) | 0.1 | $1.8M | 400k | 4.48 | |
| Fate Therapeutics (FATE) | 0.1 | $1.4M | 1.2M | 1.20 | |
| Neumora Therapeutics (NMRA) | 0.0 | $858k | 440k | 1.95 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $624k | 400k | 1.56 | |
| Rocket Pharmaceuticals (RCKT) | 0.0 | $358k | 100k | 3.58 |
